# PRPF38A

## Overview
PRPF38A is a gene that encodes the protein pre-mRNA processing factor 38A, which is a vital component of the spliceosome, a complex responsible for the splicing of pre-mRNA. This protein plays a significant role in the regulation of mRNA processing within the nucleus, influencing protein synthesis and cellular function (Chen2007Proteomic). As a spliceosomal protein, PRPF38A is involved in the precise removal of introns from pre-mRNA transcripts, a critical step in mRNA maturation. The protein's function is essential for the generation of mature mRNA molecules, which are subsequently translated into functional proteins, thereby impacting cellular activities and organismal development (Chen2007Proteomic). PRPF38A has also been implicated in various clinical conditions, including its potential role as a biomarker for osteosarcoma, highlighting its importance in both normal cellular processes and disease states (Chang2020Differentially).

## Structure
PRPF38A encodes a protein that plays a critical role in pre-mRNA splicing. The primary structure of the PRPF38A protein is defined by its unique sequence of amino acids, which determines its specific function in the spliceosome. The secondary structure of PRPF38A may include elements such as alpha helices and beta sheets, contributing to its stability and interaction with other spliceosomal components. The tertiary structure refers to the overall three-dimensional conformation of the protein, which is essential for its biological activity. In terms of quaternary structure, PRPF38A may interact with other protein subunits, forming a complex that is integral to its role in the spliceosome.

PRPF38A may contain specific domains that are crucial for its function, although detailed information on these domains is not provided. Post-translational modifications, such as phosphorylation, can modulate the activity of PRPF38A, potentially affecting its interaction with other proteins and its role in splicing. Additionally, splice variant isoforms of PRPF38A may exist, which could lead to variations in its structure and function, allowing for diverse regulatory mechanisms in mRNA processing. These structural features underscore the importance of PRPF38A in the precise regulation of gene expression.

## Function
PRPF38A (pre-mRNA processing factor 38A) is a crucial component of the spliceosome, the complex responsible for the removal of introns from pre-mRNA transcripts, a key step in mRNA maturation. This protein is active in the nucleus, where it plays a significant role in the regulation of mRNA processing, impacting protein synthesis and cellular function (Chen2007Proteomic). The spliceosome is a dynamic assembly of snRNPs (small nuclear ribonucleoproteins) and various associated proteins, including PRPF38A, which work together to ensure accurate splicing of pre-mRNA. This process is essential for the generation of mature mRNA molecules that are translated into functional proteins, thereby influencing cellular activities and organismal development (Chen2007Proteomic).

In the context of osteosarcoma, PRPF38A has been identified as a gene closely associated with the spliceosome signaling pathway, suggesting its potential role as a biomarker for this type of cancer (Chang2020Differentially). The involvement of PRPF38A in such pathways underscores its importance in maintaining normal cellular processes and highlights its potential impact when dysregulated.

## Clinical Significance
PRPF38A has been implicated in several clinical conditions due to its role in pre-mRNA splicing. Alterations in PRPF38A expression have been associated with aging processes. In Caenorhabditis elegans, post-developmental inactivation of the ortholog of human PRPF38A was found to extend lifespan, suggesting a potential link between PRPF38A expression and aging (Angarola2021Splicing). Additionally, PRPF38A is involved in bone biology, particularly in osteoblast differentiation and bone mineralization. Knockdown of PRPF38A in osteoblasts led to increased expression of adipogenic transcription factors, indicating a shift towards adipogenic differentiation. This suggests that PRPF38A may play a role in maintaining the balance between adipogenic and osteogenic differentiation, which is crucial for bone homeostasis and conditions like osteoporosis (Cousminer2021Genomewide).

PRPF38A has also been identified as a potential biomarker for osteosarcoma, a type of bone cancer. It is closely associated with the spliceosome signaling pathway, which may be crucial for understanding the molecular mechanisms underlying osteosarcoma (Chang2020Differentially). These findings highlight the importance of PRPF38A in various physiological and pathological processes.

## Interactions
PRPF38A is a component of the spliceosome, a complex responsible for pre-mRNA splicing. It interacts with various spliceosomal proteins, playing a crucial role in the assembly and function of the spliceosome. In the context of osteosarcoma, PRPF38A has been identified as a potential biomarker due to its association with the spliceosome signaling pathway. This association was highlighted in a study that identified differentially expressed genes in osteosarcoma, where PRPF38A was one of the 22 hub genes within a protein-protein interaction network constructed using STRING online software (Chang2020Differentially).

PRPF38A is also mentioned in the context of its interactions with other spliceosomal components. Although specific interactions with C9ORF78 are not detailed, PRPF38A is enriched in the Flag-C9ORF78 R41A IP, indicating potential interactions with C9ORF78 during the B-to-B act transition of the spliceosome (Bergfort2022A). Additionally, PRPF38A is noted in studies involving the SANS (USH1G) gene, which regulates pre-mRNA splicing by mediating the intra-nuclear transfer of tri-snRNP complexes. However, specific interactions between PRPF38A and SANS are not detailed in the provided context (Yildirim2020SANS).


## References


1. (Chang2020Differentially) Differentially expressed genes SNRPC and PRPF38A are potential biomarkers candidates for osteosarcoma. This article has 1 citations.

[2. (Angarola2021Splicing) Brittany Lynn Angarola and Olga Anczuków. Splicing alterations in healthy aging and disease. WIREs RNA, February 2021. URL: http://dx.doi.org/10.1002/wrna.1643, doi:10.1002/wrna.1643. This article has 27 citations.](https://doi.org/10.1002/wrna.1643)

[3. (Cousminer2021Genomewide) Diana L. Cousminer, Yadav Wagley, James A. Pippin, Ahmed Elhakeem, Gregory P. Way, Matthew C. Pahl, Shana E. McCormack, Alessandra Chesi, Jonathan A. Mitchell, Joseph M. Kindler, Denis Baird, April Hartley, Laura Howe, Heidi J. Kalkwarf, Joan M. Lappe, Sumei Lu, Michelle E. Leonard, Matthew E. Johnson, Hakon Hakonarson, Vicente Gilsanz, John A. Shepherd, Sharon E. Oberfield, Casey S. Greene, Andrea Kelly, Deborah A. Lawlor, Benjamin F. Voight, Andrew D. Wells, Babette S. Zemel, Kurt D. Hankenson, and Struan F. A. Grant. Genome-wide association study implicates novel loci and reveals candidate effector genes for longitudinal pediatric bone accrual. Genome Biology, January 2021. URL: http://dx.doi.org/10.1186/s13059-020-02207-9, doi:10.1186/s13059-020-02207-9. This article has 72 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/s13059-020-02207-9)

4. (Yildirim2020SANS) SANS (USH1G) regulates pre-mRNA splicing by mediating the intra-nuclear transfer of tri-snRNP complexes. This article has 0 citations.

[5. (Bergfort2022A) Alexandra Bergfort, Marco Preußner, Benno Kuropka, İbrahim Avşar Ilik, Tarek Hilal, Gert Weber, Christian Freund, Tuğçe Aktaş, Florian Heyd, and Markus C. Wahl. A multi-factor trafficking site on the spliceosome remodeling enzyme brr2 recruits c9orf78 to regulate alternative splicing. Nature Communications, March 2022. URL: http://dx.doi.org/10.1038/s41467-022-28754-2, doi:10.1038/s41467-022-28754-2. This article has 8 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-022-28754-2)

[6. (Chen2007Proteomic) Yen-I G. Chen, Roger E. Moore, Helen Y. Ge, Mary K. Young, Terry D. Lee, and Scott W. Stevens. Proteomic analysis of in vivo-assembled pre-mrna splicing complexes expands the catalog of participating factors. Nucleic Acids Research, 35(12):3928–3944, May 2007. URL: http://dx.doi.org/10.1093/nar/gkm347, doi:10.1093/nar/gkm347. This article has 92 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkm347)